Search NASA⌕ Search

Engineering topics

Valente, M

Publications and source records attributed to Valente, M.

Calculation of electron and isotopes dose point kernels with fluka Monte Carlo code for dosimetry in nuclear medicine therapy

Purpose: The calculation of patient-specific dose distribution can be achieved by Monte Carlo simulations or by analytical methods. In this study, fluka Monte Carlo code has been considered for use in nuclear medicine dosimetry. Up to now, fluka has mainly been dedicated to other fields, namely high energy physics, radiation protection, and hadrontherapy. When first employing a Monte Carlo code for nuclear medicine dosimetry, its results concerning electron transport at energies typical of nuclear medicine applications need to be verified. This is commonly achieved by means of calculation of a representative parameter and comparison with reference data. Dose point kernel (DPK), quantifying the energy deposition all around a point isotropic source, is often the one. Methods: fluka DPKs have been calculated in both water and compact bone for monoenergetic electrons (10{sup -3} MeV) and for beta emitting isotopes commonly used for therapy ({sup 89}Sr, {sup 90}Y, {sup 131}I, {sup 153}Sm, {sup 177}Lu, {sup 186}Re, and {sup 188}Re). Point isotropic sources have been simulated at the center of a water (bone) sphere, and deposed energy has been tallied in concentric shells. fluka outcomes have been compared to penelope v.2008 results, calculated in this study as well. Moreover, in case of monoenergetic electrons in water, comparison with the data from the literature (etran, geant4, mcnpx) has been done. Maximum percentage differences within 0.8{center_dot}R{sub CSDA} and 0.9{center_dot}R{sub CSDA} for monoenergetic electrons (R{sub CSDA} being the continuous slowing down approximation range) and within 0.8{center_dot}X{sub 90} and 0.9{center_dot}X{sub 90} for isotopes (X{sub 90} being the radius of the sphere in which 90% of the emitted energy is absorbed) have been computed, together with the average percentage difference within 0.9{center_dot}R{sub CSDA} and 0.9{center_dot}X{sub 90} for electrons and isotopes, respectively. Results: Concerning monoenergetic electrons, within 0.8{center_dot}R{sub CSDA} (where 90%-97% of the particle energy is deposed), fluka and penelope agree mostly within 7%, except for 10 and 20 keV electrons (12% in water, 8.3% in bone). The discrepancies between fluka and the other codes are of the same order of magnitude than those observed when comparing the other codes among them, which can be referred to the different simulation algorithms. When considering the beta spectra, discrepancies notably reduce: within 0.9{center_dot}X{sub 90}, fluka and penelope differ for less than 1% in water and less than 2% in bone with any of the isotopes here considered. Complete data of fluka DPKs are given as Supplementary Material as a tool to perform dosimetry by analytical point kernel convolution. Conclusions: fluka provides reliable results when transporting electrons in the low energy range, proving to be an adequate tool for nuclear medicine dosimetry.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Developing and improving a scanning system for dosimetric applications

Radiotherapy is nowadays one of the most used techniques for the treatment of different pathologies, particularly cancer diseases. The accuracy regarding the application of these treatments, which are planned according to patient information, depends mainly on the dosimetric measurements of absorbed dose within irradiated tissues. The present work is devoted to the study, design and construction of an original device capable of performing visible light transmission measurements in order to analyze Fricke gel dosimeters. Furthermore, a suitable bi-dimensional positioning system along with a dedicated control system and image processing software has been adapted to the dosimetric device in order to perform 2D dose mapping. The obtained results confirm the feasibility of the proposed method, therefore suggesting its potentiality for clinical applications.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

3D dose and TCP distribution for radionuclide therapy in nuclear medicine

A common feature to any radiant therapy is that lesion and health tissue dosimetry provides relevant information for treatment optimization along with dose-efficacy and dose-complication correlation studies. Nowadays, different radionuclide therapies are commonly available, assessing both systemic and loco-regional approach and using different alfa-, beta-and gamma-emitting isotopes and binding molecules. It is well established, that specific dosimetric approaches become necessary according to each therapy modality. Sometimes, observed activity distribution can be satisfactory represented by simple geometrical models. However, Monte Carlo techniques are capable of better approaches, therefore becoming sometimes the only way to get dosimetric data since the patient-specific situation can not be adequately represented by conventional dosimetry techniques. Therefore, due to strong limitations of traditional and standard methods, this work concentrates on the development of a dedicated and novel calculation system in order to assess the dose distribution within the irradiated patient. However, physical dose may not be enough information in order to establish real deterministic biological/metabolic effects; therefore complementary radiobiological models have been suitably introduced with the aim of performing realistic 3D dose as well as corresponding Tumor Control Probability distribution calculation.

62 RADIOLOGY AND NUCLEAR MEDICINE↗